Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Share-based Compensation (2016 - 2025)

Nephros (NEPH) has 16 years of Share-based Compensation data on record, last reported at $70000.0 in Q3 2025.

  • For Q3 2025, Share-based Compensation rose 7.69% year-over-year to $70000.0; the TTM value through Sep 2025 reached $279000.0, up 21.83%, while the annual FY2024 figure was $153000.0, 80.88% down from the prior year.
  • Share-based Compensation reached $70000.0 in Q3 2025 per NEPH's latest filing, down from $71000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $319000.0 in Q1 2023 and bottomed at -$9000.0 in Q1 2024.
  • Average Share-based Compensation over 5 years is $156315.8, with a median of $138000.0 recorded in 2023.
  • Peak YoY movement for Share-based Compensation: crashed 102.82% in 2024, then skyrocketed 944.44% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $75000.0 in 2021, then grew by 29.33% to $97000.0 in 2022, then skyrocketed by 42.27% to $138000.0 in 2023, then plummeted by 55.07% to $62000.0 in 2024, then increased by 12.9% to $70000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $70000.0 in Q3 2025, $71000.0 in Q2 2025, and $76000.0 in Q1 2025.